Jiang Linlin, Qian Yifan, Chen Xiaoli, Ji Xiaohui, Ou Songbang, Li Ruiqi, Yang Dongzi, Li Yu
Department of Obstetrics and Gynecology Sun Yat-Sen Memorial Hospital Sun Yat-Sen University Guangzhou China.
Reprod Med Biol. 2021 Oct 27;21(1):e12420. doi: 10.1002/rmb2.12420. eCollection 2022 Jan.
To determine the utility of short gamete coincubation in fertilization (IVF-S) combined with early rescue intracytoplasmic sperm injection (R-ICSI) and split IVF-ICSI in preventing low fertilization based on a retrospective cohort study.
Couples with a high risk of low IVF fertilization during the first ART cycle underwent IVF-S with R-ICSI or split IVF-ICSI. Fertilization rate, embryo quality, and clinical outcomes were measured.
After propensity score matching, we included 188 couples in the IVF-S with R-ICSI group as Group 1 and 720 in the split IVF-ICSI group as Group 2. Normal fertilization rates were similar; however, Group 1 had a higher multiple pronuclei rate (10.42% vs. 4.50%, < 0.001) but a higher embryo utilization rate (59.84% vs. 53.60%, < 0.001). The groups were similar in the rates of high-quality embryos, embryo implantation, clinical pregnancy, and live birth. Low IVF fertilization rate was 4.79% and 9.03% in Group 1 and Group 2, respectively, with similar fertilization rate and embryo development.
IVF-S with early R-ICSI and split IVF-ICSI were effective strategies in preventing low fertilization rate. IVF-S with early R-ICSI could become the preferred approach because of its advantages-higher embryo utilization rate, fewer ICSI procedures, similar clinical pregnancy rate, and live birth rate.
基于一项回顾性队列研究,确定短配子共孵育受精(IVF-S)联合早期补救性卵胞浆内单精子注射(R-ICSI)以及分步IVF-ICSI在预防低受精方面的效用。
在首个辅助生殖技术周期中存在IVF低受精高风险的夫妇接受了IVF-S联合R-ICSI或分步IVF-ICSI。测量受精率、胚胎质量和临床结局。
在倾向评分匹配后,我们将188对夫妇纳入IVF-S联合R-ICSI组作为第1组,720对夫妇纳入分步IVF-ICSI组作为第2组。正常受精率相似;然而,第1组有更高的多原核率(10.42%对4.50%,<0.001),但胚胎利用率更高(59.84%对53.60%,<0.001)。两组在优质胚胎率、胚胎着床、临床妊娠和活产率方面相似。第1组和第2组的IVF低受精率分别为4.79%和9.03%,受精率和胚胎发育相似。
IVF-S联合早期R-ICSI以及分步IVF-ICSI是预防低受精率的有效策略。IVF-S联合早期R-ICSI因其优势——更高的胚胎利用率、更少的ICSI操作、相似的临床妊娠率和活产率——可能成为首选方法。